Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Net income (loss)	$ 165,198	$ (120,111)
Adjustments to reconcile net income (loss) to net cash provided (used) in operating activities:
Depreciation and amortization	3,054	8,664
Interest receivable	(2,106)	(2,152)
Increase (decrease) in cash flows as a result of changes in net assets and liabilities balances:
Accounts receivable	(164,620)	(19,499)
Inventory	(183,704)	(22,763)
Prepaid expenses and other current assets	(5,819)	(1,135)
Accounts payable	51,282	53,449
Customer deposit	103,492	36,636
Due to shareholder	57,894
Accrued expenses and other current liabilities	60,369	(2,877)
Net cash provided (used) in operating activities	85,040	(69,788)
Cash flows from investing activities:
Restricted cash	(261)	(393)
Other assets Investment in Angiodroid	(1,000)
Net cash provided (used) by investing activities	(1,261)	(393)
Cash flows used in financing activities:
Repayments on note payable - Bank	(7,000)	(6,000)
Net cash used in financing activities	(7,000)	(6,000)
Net increase (decrease) in cash and cash equivalents	76,779	(76,181)
Cash and cash equivalents - beginning of year	83,156	105,087
Cash and cash equivalents - end of year	159,935	28,906
Cash paid for:
Interest	$ 1,693	$ 1,571